Federated Identity Credentials provide a way to avoid managing secrets or certificates. In this case, you will rely on Managed Identity to issue a credential. Note that you should use Managed Identity ...

The European Commission (EC) will now review the CHMP recommendation, and a decision on the label extension application of IXCHIQ® in the European Union (EU), Norway, Liechtenstein and Iceland is ...

The European Medicines Agency’s CHMP regulatory committee gave a positive opinion to add a self-administration option for asthma injection Fasenra (benralizumab), based on a new delivery method ...

Cisco warned customers today of a vulnerability in Webex for BroadWorks that could let unauthenticated attackers access credentials remotely. Webex for BroadWorks integrates Cisco Webex's video ...

The Committee for Medicinal Products for Human Use (CHMP) has also recommended J&J’s Stelara (ustekinumab) to treat paediatric patients weighing at least 40kg with moderately to severely active CD, ...

Credential stuffing attacks had a huge impact in 2024, fueled by a vicious circle of infostealer infections and data breaches. But things could be about to get worse still with Computer-Using Agents, ...

Novartis NVS announced that the Committee for Medicinal Products for Human Use (“CHMP”) of the European Medicines Agency has adopted a positive opinion for the label expansion of Fabhalta ...

The Committee for Medicinal Products for Human Use (CHMP) has recommended that the topical gene therapy be approved to treat wounds in DEB patients of all ages in either a healthcare setting or at ...

The Committee for Medicinal Products for Human Use (CHMP), which prepares the European Medicines Agency’s opinion about medical drugs for human use, said on Friday that its prior recommendation for ...

The CHMP’s positive opinion includes support for administration of VYJUVEK in either a health care setting (e.g., a clinic) or at home. If deemed appropriate by a healthcare professional, trained ...

The European Medicines Agency’s (EMA) human medicines committee (CHMP) recommended three novel medicines for approval at its February 2025 meeting. The European Commission is expected to announce a ...